‌

US Patent 7700594 Fused bicyclic mTOR inhibitors

Patent 7700594 was granted and assigned to OSI Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

OSI Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7700594

Date of Patent

April 20, 2010

Patent Application Number

11599663

Date Filed

November 15, 2006

Patent Citations Received

‌

US Patent 11673894 Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

‌

US Patent 11999740 Fused pyrazine derivatives as A2A / A2B inhibitors

‌

US Patent 11884665 Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

‌

US Patent 11873304 Fused pyrimidine derivatives as A2A/A2B inhibitors

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

Compounds represented by Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7700594 Fused bicyclic mTOR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API